Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ouedraogo, R.
Right arrow Articles by Kirchgessner, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ouedraogo, R.
Right arrow Articles by Kirchgessner, A. L.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 52:111-117, 2003
© 2003 by the American Diabetes Association, Inc.

Glucose Regulates the Release of Orexin-A From the Endocrine Pancreas

Raogo Ouedraogo1, Erik Näslund2, and Annette L. Kirchgessner1

1 Department of Physiology and Pharmacology, State University of New York, Downstate Medical Center, Brooklyn, New York
2 Division of Surgery, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden

Orexins (hypocretins) are novel neuropeptides that appear to play a role in the regulation of energy balances. Orexin-A (OXA) increases food intake in rodents, and fasting activates OXA neurons in both the lateral hypothalamic area and gut. OXA is also found in the endocrine pancreas; however, little is known about its release or functional significance. In this study, we show that depolarizing stimuli evoke the release of OXA from rat pancreatic islets in a calcium-dependent manner. Moreover, OXA release is stimulated by low glucose (2.8 mmol/l), similar to glucagon secretion, and inhibited by high glucose (16.7 mmol/l). Fasting increases plasma OXA, supporting the idea that orexin is released in response to hypoglycemia. Cells that secrete glucagon and insulin contain OXA and both cell types express orexin receptors. OXA increases glucagon secretion and decreases glucose-stimulated insulin release from isolated islets. OXA infusion increases plasma glucagon and glucose levels and decreases plasma insulin in fasted rats. We conclude that orexin-containing islet cells, like those in the brain and gut, are glucosensitive and part of a network of glucose "sensing" cells that becomes activated when blood glucose levels fall. OXA may modulate islet hormone secretion to maintain blood glucose levels during fasting.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
R. Ducroc, T. Voisin, A. El Firar, and M. Laburthe
Orexins Control Intestinal Glucose Transport by Distinct Neuronal, Endocrine, and Direct Epithelial Pathways
Diabetes, October 1, 2007; 56(10): 2494 - 2500.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. Arumugam, D. Fleenor, and M. Freemark
Lactogenic and Somatogenic Hormones Regulate the Expression of Neuropeptide Y and Cocaine- and Amphetamine-Regulated Transcript in Rat Insulinoma (INS-1) Cells: Interactions with Glucose and Glucocorticoids
Endocrinology, January 1, 2007; 148(1): 258 - 267.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Voisin, A. E. Firar, V. Avondo, and M. Laburthe
Orexin-Induced Apoptosis: The Key Role of the Seven-Transmembrane Domain Orexin Type 2 Receptor
Endocrinology, October 1, 2006; 147(10): 4977 - 4984.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
R. Spinazzi, P. G. Andreis, G. P. Rossi, and G. G. Nussdorfer
Orexins in the regulation of the hypothalamic-pituitary-adrenal axis.
Pharmacol. Rev., March 1, 2006; 58(1): 46 - 57.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Ammoun, L. Johansson, M. E. Ekholm, T. Holmqvist, A. S. Danis, L. Korhonen, O. A. Sergeeva, H. L. Haas, K. E. O. Akerman, and J. P. Kukkonen
OX1 Orexin Receptors Activate Extracellular Signal-Regulated Kinase in Chinese Hamster Ovary Cells via Multiple Mechanisms: The Role of Ca2+ Influx in OX1 Receptor Signaling
Mol. Endocrinol., January 1, 2006; 20(1): 80 - 99.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. K. Young, M. Wu, K. F. Manaye, P. Kc, J. S. Allard, S. O. Mack, and M. A. Haxhiu
Orexin stimulates breathing via medullary and spinal pathways
J Appl Physiol, April 1, 2005; 98(4): 1387 - 1395.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Ehrstrom, T. Gustafsson, A. Finn, A. Kirchgessner, P. Gryback, H. Jacobsson, P. M. Hellstrom, and E. Naslund
Inhibitory Effect of Exogenous Orexin A on Gastric Emptying, Plasma Leptin, and the Distribution of Orexin and Orexin Receptors in the Gut and Pancreas in Man
J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2370 - 2377.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. L. Barreiro, R. Pineda, V. M. Navarro, M. Lopez, J. S. Suominen, L. Pinilla, R. Senaris, J. Toppari, E. Aguilar, C. Dieguez, et al.
Orexin 1 Receptor Messenger Ribonucleic Acid Expression and Stimulation of Testosterone Secretion by Orexin-A in Rat Testis
Endocrinology, May 1, 2004; 145(5): 2297 - 2306.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
G. Flemstrom, M. Sjoblom, G. Jedstedt, and K. E. O. Akerman
Short fasting dramatically decreases rat duodenal secretory responsiveness to orexin A but not to VIP or melatonin
Am J Physiol Gastrointest Liver Physiol, December 1, 2003; 285(6): G1091 - G1096.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. Ehrstrom, E. Naslund, J. Ma, A. L. Kirchgessner, and P. M. Hellstrom
Physiological regulation and NO-dependent inhibition of migrating myoelectric complex in the rat small bowel by OXA
Am J Physiol Gastrointest Liver Physiol, October 1, 2003; 285(4): G688 - G695.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2003 by the American Diabetes Association.